Delve Bio

Delve Bio, a subsidiary of UCSF, has its tests developed by the Next-Generation Precision Diagnostics Center at the UCSF School. This diagnostic platform uses next-generation sequencing to analyze all nucleic acids in a single patient sample, detecting bacteria, fungi, parasites, and viruses simultaneously in a hypothesis-free manner. Delve Bio also provides a proprietary computational pipeline capable of rapidly analyzing hundreds of millions of sequences to accurately identify pathogens.